Skip to content

Clinical trials

Phase 3 Child Development Disorders, Pervasive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Child Development Disorders, Pervasive Phase: Phase 3 Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Indiana University2
Massachusetts General Hospital2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Janssen-Ortho Inc., Canada1
Ohio State University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Child Development Disorders, Pervasive7
Autistic Disorder4
Asperger Syndrome3
Autism Spectrum Disorder3
Adjustment Disorders1
Attention Deficit Disorder with Hyperactivity1
Bipolar Disorder1
Conduct Disorder1
Developmental Disabilities1
Disruptive, Impulse Control, and Conduct Disorders1

Trials

Showing 51 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.